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Clinics and pathology 
Disease 
Pericytoma with t(7;12) 
Phenotype / cell stem origin 
Unknown. 
Embryonic origin 
The cellular origin is unknown, but it presumably 
derives from the mesoderm. The tumor cells display 
cytoarchitectural, immunohistochemical and 
ultrastructural features highly suggestive of pericytic 
differentiation, and it seems likely that these lesions fall 




Presumably rare, but differential diagnostic problems 
may have hampered the distinction of these tumors in 
the past. Tumors that fall within the differential 
diagnosis include cellular examples of solitary fibrous 
tumors (also known as hemangiopericytoma), 
myofibroma (tosis), monophasic synovial sarcoma, 
mesenchymal chondrosarcoma, and metastatic 
endometrial stromal sarcoma. Affects both men and 
woman of all ages. No familial cases are known. 
Clinics 
Seems to present as a solitary pain-less nodule. The 
locations reported so far have been the tongue (3 






Pericytomas with t(7;12) display a multilobulated, 
infiltrative growth pattern, and are composed of  
uniform spindle-shaped pericytic cells that are 
consistently arranged around small, thin-walled  
arborizing vessels. The spindle cells present small 
amounts of eosinophilic cytoplasm, and ovoid-to-
tapered nuclei with vesicular chromatin and often a 
single nucleolus. No significant atypia or 
pleomorphism is present, and mitotic figures are rare. 
Treatment 
Preoperative chemotherapy has not proven efficient. 
Surgical excision seems to be the treatment of choice. 
Prognosis 
Based on a limited follow-up (22-120 months), 
pericytomas with t(7;12) are seemingly benign or low-
malignant tumors. No signs of recurrence or metastasis 
have been reported. 
Cytogenetics 
Morphological Cytogenetics 
The recurrently observed t(7;12)(p22;q13) is a specific 
translocation characteristic for the tumor type. 
Molecular Cytogenetics 
Metaphase FISH mapping analysis on one case 
revealed that the breakpoints were located to BAC 
probes RP11-1275H24, and RP11-93G19 on 7p22, and 
to BAC probes 181L23, and 772E1 on 12q13. The 
probes gave split signals on the respective derivatives. 
On the normal chromosomes, intact signals were seen. 










Representative G-banded partial karyotype of the 
t(7;12)(p22;q13). 
Probes 
BAC probes RP11-1275H24 (AC092171; substantially 
larger than the 85 kb reported by the NCBI), and RP11-
93G19 (BAC ends: AQ321651, AQ321650) spanning 
the ACTB locus, and BAC probes 181L23 
(AC022506), and 772E1 (AC063917) spanning the 
GLI1 locus. 
Genes involved and proteins 
Note 
The t(7;12)(p22;q13), fuses the ACTB gene in 7p22, to 




DNA / RNA 
Six exons, spans approximately 3.4 kb of genomic 
DNA in the centromere-to-teleomere orientation. The 
translation initiation codon ATG is located to exon 2, 
and the stop codon to exon 6. The ACTB mRNA is 
approximately 1.8 kb. ACTB is abundantly expressed 
in all mammalian and avian non-muscle cells. 
Protein 
The open reading frame encodes a 374 amino acid 
protein, with an estimated molecular weight of 
approximately 41.7 kDa. The ACTB protein is located 
in the cytoplasm where it is a component (together with 





DNA / RNA 
Twelve exons, spans approximately 12 kb of genomic 
DNA in the centromere-to-telomere orientation. The 
translation initiation codon is located in exon 2, and the 
stop codon in exon 12. The GLI1 mRNA transcript is 
3.6 kb. 
GLI proteins function as direct effectors of sonic 
hedgehog-signaling during embryogenesis. GLI1 (also 
GLI2 and GLI3) are therefore likely to be involved in 
the tissue-specific proliferation of the central nervous 
system, the zones of polarizing activity in the 
developing limb, and of the gut. In the adult human, 
GLI1 expression has been demonstrated in the testes, 
myometrium and Fallopian tubes. 
Protein 
The open reading frame encodes an 1106 amino acid 
protein, with an estimated molecular weight of 
approximately 118 kDa. The GLI protein is a DNA 
binding transcription factor, also the last known step in 
the sonic hedgehog-signaling pathway. The GLI1 
protein contains five DNA-binding zinc fingers 
between amino acids 235 and 393 (encoded by exons 
7-10), and a transactivating domain constituted by 
amino acids 1020-1091 (encoded by exon 12). 




To date, five cases of pericytoma with t(7;12) have 
been reported. All of them expressed an ACTB-GLI1 
transcript, and two of them also expressed a reciprocal 
GLI1-ACTB fusion transcript. The genomic 
breakpoints of these fusions have been characterized, 
revealing that the respective breakpoints shared short 
common oligomers. 
Detection 
A detailed description of a protocol for the detection of 




The function of the ACTB-GLI1 chimera is unknown, 
but it is suggested that the strong ACTB promoter 
causes an over-expression of GLI1 sequences important 
for transcriptional activation of downstream target 
genes. 
Description 
The ACTB-GLI1 fusion protein contains the N-
terminal of ACTB and the C-terminal of GLI1, 
including the DNA-binding zinc finger motifs (encoded 
by exons 7-10) and transactivating motifs (exon 12). 
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